Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Epalinges
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- N/A
- Filings on record
- 440 filings
- On EDGAR
- CIK 1771910
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 141
News 8 of 38
Prospectuses and Registrations 8 of 39
- S-4 Registration statement for a merger or exchange Nov 3, 2026
- S-8 Registration statement for an employee plan Aug 13, 2026
- 424B3 Prospectus supplement for an offering Apr 15, 2026
- 424B3 Prospectus supplement for an offering Mar 16, 2026
- S-3 Shelf registration statement Mar 10, 2026
- 424B3 Prospectus supplement for an offering Dec 12, 2025
- S-3/A Shelf registration statement, amended Dec 9, 2025
- S-3 Shelf registration statement Nov 10, 2025
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 20, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 20, 2026
- PRE 14A Preliminary proxy statement Apr 10, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2025
- DEFA14A Extra proxy material Apr 21, 2025
- PRE 14A Preliminary proxy statement Apr 9, 2025
- DEFA14A Extra proxy material Sep 23, 2024
- DEF 14A Proxy statement for a shareholder vote Sep 23, 2024
Ownership 8 of 138
- SCHEDULE 13G Large holder reported a passive stake Oct 29, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 27, 2026
- 4 Insider reported a trade Jul 2, 2026
- 4 Insider reported a trade Jul 2, 2026
- 4 Insider reported a trade Jul 2, 2026
- 4 Insider reported a trade Jul 2, 2026
- 4 Insider reported a trade Jun 3, 2026
Other 8 of 72
- EFFECT Notice that a registration became effective Mar 16, 2026
- CORRESP Reply to SEC staff Mar 12, 2026
- UPLOAD Comment letter from SEC staff Mar 12, 2026
- ARS Annual report sent to shareholders Mar 10, 2026
- EFFECT Notice that a registration became effective Dec 12, 2025
- CORRESP Reply to SEC staff Dec 10, 2025
- EFFECT Notice that a registration became effective Jul 9, 2025
- CORRESP Reply to SEC staff Jul 7, 2025
Everything here comes from ADC Therapeutics SA's own filings on SEC EDGAR. The filing list is rechecked every hour.